surmount-1 tirzepatide 15 mg weight loss percent Tirzepatide: In the trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 TrimRX | Tirzepatide Results Timeline:
Description
Hydration: Keep fluids up, particularly while titrating, when GI effects peak

Initially developed to combat type 2 diabetes, Tirzepatide has also demonstrated cardiovascular protection and potent weight loss effects

GLP-1 signalling slows gastric emptying and blunts appetite centrally

By promoting satiety and steady blood sugar control, this treatment supports sustainable weight management when combined with lifestyle guidance and medical oversight

Even for formulations without B12, avoiding direct light exposure is good practice

SURMOUNT-1 (Jastreboff et al., NEJM 2022) reported 22.5% body weight loss at 72 weeks at the 15 mg dose
